INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 4
RESEARCH DOSSIER / NOT AN ENDORSEMENT

FuturHealth

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'The future of your health starts today'; 'Join over 400,000 people'; full program (meds + GLP-1 meal plans + movement); 'lose 58.5% more weight with full program vs medicine alone' (retrospective study); 4.7 / 13,000+ reviews. Brand-name and oral (Foundayo, Wegovy pill) focus.

Audienceread

Read: mainstream adults wanting a structured, 'full program' (nutrition + fitness) approach; Apple ecosystem users; physician-led credibility (named MDs, RD).

Pricing & termspartial

Intro-month advertising: Wegovy pill from $198/month; Zepbound KwikPen from $395/month. Current terms explicitly say the subscription fee does NOT include medication, labs or additional provider fees. A comparable ongoing all-in total is not established.

Clinical relationshipsverified

SteadyMD; OpenLoop; groups supported by CareValidate

Pharmacy & fulfillmentpartial

Independent licensed pharmacies; names not specified in terms

Advertising snapshotsnapshot

Google domain lookup (US, last 30 days): 25 ads. Recent domain-result ads observed under US / Last 30 days. Domain results include multiple advertiser accounts, and may include non-GLP products. sample last shown: Oct 11, 2026. Meta active exact-phrase keyword lookup: ~120 results. Active cards are present in the keyword result set; attribution to the brand is limited where content is age-gated.

Founding yearpartial

2023 (BBB business started 11/17/2023)

Foundersverified

Luke Mahoney (co-founder/CEO); John Levan (co-founder/President)

Location & entity contextpartial

San Diego, California (325 W Washington St Ste 2)

Search visibility samplepartial

Free index sample: 3 domain-restricted pages and 3 brand+GLP results. Example pages: FuturHealth Releases New Efficacy Data Demonstrating Enhanced Weight Loss Outcomes with GLP-1 Treatments | FuturHealth; Products & Services | Weight Loss Medication, Telehealth Dietitians and Personalized Diet Plans; STUDY PROTOCOL. No appearance in the checked 15-result samples for GLP-1 online weight loss, compounded semaglutide online, and compounded tirzepatide online.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.